Dermatology - DelRicht Research

Dermatology

Dermatology Trials Conducted

Dermatology Participants Enrolled

Dermatology Sites Nationwide

DelRicht Has Supported 11 FDA Approvals in Dermatology

At DelRicht Research, we have a specialized network of sites focused on dermatology, offering unrivaled patient access and investigator support for your research programs. Our commitment to advancing dermatology research is reflected in our partnerships with leading physicians and healthcare facilities.

Therapeutic Expertise

Our expertise in dermatology research includes, but is not limited to:

  • Medical Dermatology: Acne, Atopic Dermatitis (AD), Chronic Pruritus, Chronic Spontaneous Urticaria, Common Warts, Hyperhidrosis, Hidradenitis Suppurativa, Prurigo Nodularis, Actinic Keratosis, Rosacea, Psoriasis, Acne Vaccine, Vitiligo, Hair Loss (Androgenetic Alopecia)
  • Cosmetic Dermatology: Cellulite, Cheek Wrinkles, Glabellar Lines, Midface Contour Deficiency, Platysma Prominence, Platysmal Bands, Temple Hollowing, Sagging Jawline, Transverse Neck Lines

x42 Sites Recognized as Top Enroller Status

x13 First Patient Screened or Enrolled

Capabilities

DelRicht Research’s broad network provides access to diverse dermatology patients and supports high-quality studies with experienced physicians and staff. Key capabilities include:

  • High-Resolution Digital Photography for Dermatologic Assessments
  • Lesion and Rash Severity Scoring (IGA, PASI, EASI, BSA)
  • Biopsy and Histopathology Coordination
  • Topical, IV, Subcutaneous, and Systemic Investigational Product Administration
  • Phototherapy Capabilities (NB-UVB, PUVA)
  • Dermatology-Specific Patient-Reported Outcome Measures (e.g., DLQI, Itch NRS)
  • Patch Testing and Contact Dermatitis Evaluation
  • Cosmetic and Procedural Dermatology Experience (Botulinum toxins, Fillers, Laser)
  • Longitudinal Tracking of Chronic Dermatologic Conditions via ePRO Systems
  • Tracking System to Monitor Medical Equipment, Location, Calibration, Usage, and Maintenance
  • Training Tracking System to Monitor Study Staff and Site Certifications and Licensure

8 Dermatology Principal Investigators

160+ Years of Collective PI Experience

Meet Some Of Our Investigators

Ira Thorla, MD

Board Certified, Dermatology

Sarah Jackson, MD

Board Certified, Dermatology

Deirdre Hooper, MD

Board Certified, Dermatology

Zachary Eyre, MD

Board Certified, Dermatology

Pezhman Shoureshi, MD

Board Certified, Dermatology

Christopher Kling, MD

Board Certified, Dermatology

Case Studies & Trial Highlights

First Patient

Randomized in a Phase 2 Urticaria Trial

Enrolled 300%

of the Expected Goal for a US-Based Phase 2 Urticaria Trial

Author Invite

Dr. Ira Thorla Invited as Author for Encore Presentation at EADV 2025

Dermatology FDA Approvals

Dermatology

Site Network of Choice

See Our Dermatology Locations

Let's talk about your next trial.